News
Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...
Open Text (OTEX) is a top GARP buy with strong AI growth, solid fundamentals, and dividends. Read here for an investment analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback